Análise do comportamento dos sintomas de ansiedade e depressão durante o primeiro mês de abstinência tabagística

• Autor(a) principal: Almeida, Amanda Correa de [UNESP]
• Data de Publicação: 2015
• Outros Autores: Ramos, Dionei [UNESP], Freire, Ana Paula Coelho Figueira [UNESP], Uzeloto, Juliana Souza [UNESP], Ramos, Ercy Mara Cipulo [UNESP]
• Tipo de documento: Artigo de conferência
• Idioma: por
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://200.145.6.205/index.php/congressoextensao/8congressoextensao/paper/view/945; http://hdl.handle.net/11449/142292
• topic: Anxiety; Depression; Smoking; Ansiedade; Depressão; Tabagismo

INTRODUCTION: It is known that smoking causes a complex dependency mechanism. There are several factors that can hinder the smoking cessation, among these one can highlight the symptoms of anxiety and depression. Thus, it is essential to know the behavior of these symptoms to enrich the treatment and intervention to smoking. OBJECTIVE: To evaluate the behavior of anxiety and depression in individuals in the first month of tobacco smoke cessation. METHODS: The study was approved by the Ethics Committee and institutional research (245/2008) and included 14 individuals smokers of both sexes, from the smoking cessation program from FCTUNESP. An initial assessment was conducted for collection of anthropometric data, disease history, and level of dependency to nicotine through the Fargestrom test. Were excluded patients with a history of anxiety and depression diagnosed and individuals who did not use pharmacological therapy treatment proposed cessation (nicotine replacement therapy and Bupropion). To evaluate anxiety and depression was used the questionnaire HADS (Hospital Anxiety and Drepession Scale), applied in 5 periods: T0 (Basal-individual still smoking) T1 (first day of abstinence), T2 (seventh day), T3 (seventeenth day of abstinence) and T4 (29 day). These evaluation periods resulted from meetings held by handling the termination. These dates are defined by a calendar produced by the treatment team. ANOVA test was used for repeated measures or Friedman according to the normality of the data. RESULTS: The individuals evaluated 64.3% are male and 35.7% female. Showed an average age of 53 ± 12.56 years, BMI 26.95 ± 3, 702kg/cm2 average and nicotine dependence level of 6.385 ± 2.063 points, which features a high level of dependency to nicotine. In relation to levels of anxiety, comparing the baseline time (T0) with T1, there was a significant increase of 4.154 ± 2.60 points to 6.615 ± 3.798 (p < 0.001), to the other periods analyzed there was no significant difference. In relation to indices of depression, comparing the baseline period with T2, T3 and T4, there was a significant decrease of: 5,615±5,268 to 3±4,32, 3±3,76, 3,53±3,66, respectively (p = 0.007), for the period T1 there was no significant difference. CONCLUSION: There was an increase of anxiety during the first days of the abstinence, compared to the baseline period. In addition, reduction in signs of depression from the seventh day of abstinence.